β Home
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (465) π οΈ Industry Q&A (98) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ Core Facts
| CEO | Mr. Naoki Okamura BSc |
| Employees | 14754 |
| Phone | 81 3 3244 3000 |
| Address | 2-5-1, Nihonbashi-Honcho Tokyo null 103-8411 JP |
| IPO Date | 2009-12-29 |
| Average Volumes | 188654 |
| Market Cap | 16.451 B USD |
| Div >7% since | N/A |
| Web | https://www.astellas.com/en/ |
| ISIN | JP3942400007 |
| NASDAQ ticker | ALPMY |
| News on YouTube | YouTube |
| SEC | 'Astellas Pharma' on SEC |
| Reports | 'Astellas Pharma' Reports |
| CUSIP | 04623U102 |
